Medicinova Inc (MNOV): EBITDA
-$13.26M
Year ended 2025-12-31
-$11.83M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$13.26M | n/m | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | -$12.65M | n/m | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | -$9.88M | n/m | 2025-02-19, From 2023-01-01 |
| 2022-12-31 | -$14.61M | n/m | 2024-02-15, From 2022-01-01 |
| 2021-12-31 | -$10.19M | n/m | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | -$14.16M | n/m | 2022-02-16, From 2020-01-01 |
| 2019-12-31 | -$14.01M | n/m | 2021-02-19, From 2019-01-01 |
| 2018-12-31 | -$15.56M | n/m | 2020-02-13, From 2018-01-01 |
| 2017-12-31 | -$13.00M | n/m | 2019-02-13, From 2017-01-01 |
| 2016-12-31 | -$10.87M | n/m | 2019-02-13, From 2016-01-01 |
| 2015-12-31 | -$8.80M | n/m | 2018-02-13, From 2015-01-01 |
| 2014-12-31 | -$9.18M | n/m | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | -$3.92M | n/m | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | -$10.88M | n/m | 2014-03-27, From 2012-01-01 |
| 2011-12-31 | -$16.07M | n/m | 2013-03-28, From 2011-01-01 |
| 2010-12-31 | -$17.77M | n/m | 2012-03-29, From 2010-01-01 |
| 2009-12-31 | -$21.02M | n/a | 2012-03-29, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Medicinova Inc (MNOV) | 2025-12-31 | -$13.26M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$9.93M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | -$42.10M | n/a |
| Allarity Therapeutics, Inc. (ALLR) | 2024-12-31 | -$27.23M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$10.44M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$5.08M | n/m |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | -$15.52M | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$29.73M | n/m |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$776.9K | n/m |
Compare MNOV, CANF, SCNX, ALLR side by side · Screen every company in Pharmaceutical Preparations ↗